UPDATED on Dec. 11, 2018 with photo from the Dec, 10, 2018 ceremony.
ORIGINAL STORY: James P. Allison, Ph.D., an immunologist at The University of Texas MD Anderson Cancer Center, is in Sweden to receive the 2018 Nobel Prize in Physiology or Medicine jointly with Japanese immunologist Tasuku Honjo, M.D., Ph.D.
The pair were announced on Oct. 1 as laureates for the discovery of cancer therapies that stimulate the immune system to attack tumor cells. Treatments developed from Allison’s work have extended the lives of thousands of people with advanced disease, though certain cancers have responded better to immunotherapy than others.
Allison delivered his Nobel lecture entitled “Immune Checkpoint Blockade in Cancer Therapy: New insights, opportunities, and prospects for cures” on Dec. 7 in Stockholm.
Both Allison, 70, and Honjo, 76, made discoveries that led to the development of “checkpoint inhibitors”—drugs infused into patients to block molecules that put the brakes on T cells. By releasing these brakes, the body’s own immune system is able to fight cancer.
Each scientist will receive a Nobel medal and diploma. They will also share a nearly $1 million prize.
According to MD Anderson, Allison has been busy during Nobel Week in Sweden. On Thursday, he signed the bottom of a chair at Bistro Nobel in the Nobel Museum in Stockholm’s Old Town. The ritual is part of a traditional museum visit by Nobel winners and launches the week’s events.
Laureates traditionally donate artifacts to the Nobel Museum. Allison presented the museum with the following items:
- A vial representing 9H10, a mouse-model monoclonal antibody developed in his lab in 1995 to block CTLA-4, a protein on T cells that shuts down immune response
- A vial of ipilimumab from Bristol-Myers Squibb that was developed for human use based on Allison’s work
- The first page of a 1996 article in Science that reported the success of anti-CTLA-4 treatment in freeing T cells to attack cancer in mice
- The first page of a 2015 review in Cell that was co-authored by Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology and Immunology at MD Anderson, who is the scientist’s longtime research collaborator and spouse
- A portrait of Allison and Sharma taken by a Dallas photographer
Allison is the first Nobel laureate for MD Anderson, where he is a professor and chair of the department of immunology. He is the executive director of the Immunotherapy Platform, which is part of MD Anderson’s Moon Shots Program—an ambitious effort to more rapidly reduce cancer deaths and suffering by developing advances in prevention, early detection and treatment based on scientific discoveries. In addition, Allison holds the Vivian L. Smith Distinguished Chair in Immunology and serves as deputy director of the David H. Koch Center for Applied Research of Genitourinary Cancers in the department of genitourinary medical oncology.
Read more about Allison in this profile published in the November 2018 issue of TMC Pulse.
Did you know that chronic pain affects nearly 50 million U.S. adults? #HHS recently issued new guidelines to help physicians with pain management options. Read what experts are saying about the proposed changes. https://t.co/BsZJGbxaFO
“We’re encouraged by the durability of the regimen," says @skopetz of the combination of encorafenib (Braftovi), binimetinib (Mektovi), and cetuximab (Erbitux) to treat BRAF V600E-mutant metastatic #colorectalcancer. #GI19 #CRCSM #endcancer https://t.co/OoXbFtfxw5
California: Ripon’s military heroes from past wars honored with six-foot-long photo banners https://t.co/SZ3bbyvqcH via @mantecabulletin
RT @BCMHouston_News: Did you see @BCMFromtheLabs's Image of the Month? Learn more about assembling a rotavirus factory here: https://t.co/d…
RT @MDAndersonTrial: A Phase II Study of INVAC-1 Treatment of Patients with High-Risk Chronic Lymphocytic Leukemia now Enrolling https://t.…
DYK our Outreach Physics team monitors 98% of #radiationtherapy facilities in the U.S. to ensure patients are receiving the correct dosage?Learn more about our specialized team: https://t.co/lZMlUxnvOf #endcancer
The Point-in-Time Count is one of the ways VA estimates the homeless Veteran population in the U.S. Thank you to all the volunteers who are participating in the count across America. Read about the count and last year’s results: https://t.co/omTnfYz9xQ #EndVeteranHomelessness https://t.co/gwvwRCFMHI
Vietnam Veteran receives replacement medals https://t.co/aMTfLrP5WS via @theindependent
RT @UTPhysicians: UTHealthCares, a student-led initiative to help the community, is holding their 2nd annual health fair on Saturday, Jan.…
RT @UTPhysicians: A well-woman exam is an important way to stay healthy. The main goals are to document/update your health habits and histo…
RT @UTPhysicians: Falling can lead to broken bones or disability, and each year 1 in 4 older adults are injured due to falls. To help lower…
We were honored to host The Rev. Dr. Derek. Barber King, Sr., nephew of Dr. Martin Luther King, Jr., to celebrate the life & legacy of Dr. King.Dr. King’s unwavering focus & passion will forever be an inspiration on our path forward. #MLKDay https://t.co/HimY0WY4fP
According to the American Cancer Society, obesity acts as a risk factor in developing liver, pancreatic and endometrial cancers. Here are simple exercises to sit less and move more: https://t.co/XtYhfqN2RV.
Join us for a twitter chat on Jan. 23 at 2 p.m. CST (3 p.m. ET) to discuss what you can do to have a healthy baby. #Best4YouBest4Baby #WellnessWed https://t.co/CGMqI4SmMK
CHI St. Luke's Health@CHI_StLukes
.@tdouglaslawson, President of Baylor St. Luke's Medical Center & CEO of the CHI Texas Division, led a moving ceremony with Minister Howard Watson and Reverend D. Darnell to celebrate the vital work and lasting national impact of Dr. King. https://t.co/3hAiyGJzww